Nature of UK regulator changes: Is there no way back?
This article was originally published in Clinica
When the merger took place of the UK's Medical Devices Agency with the Medicine's Control Agency to form the Medicines and Healthcare products Regulatory Agency on April 1 2003, the medical device and diagnostics industries' concerns were focused mainly on the threat of medicines-type policies increasingly influencing the sector. Some 18 months down the line, the medical devices and diagnostics industries are facing a different set of concerns, brought about by factors beyond their control and linked to being part of a different culture - one that is being affected by increased suspicion about its workings, reports Amanda Maxwell.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.